Back
Catalyst Pharmaceuticals Stock Price Chart
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!
Buy
89
CPRX
Catalyst Pharmaceuticals
Last Price:
$25.09
Seasonality Move:
9.03%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.3 | Buy |
| 20-day SMA: | 22.26 | Buy |
| 50-day SMA: | 22.56 | Buy |
| 200-day SMA: | 20.22 | Buy |
| 8-day EMA: | 15.84 | Buy |
| 20-day EMA: | 8.19 | Buy |
| 50-day EMA: | 3.66 | Buy |
| 200-day EMA: | 0.97 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.56 | Buy |
| Relative Strength Index (14 RSI): | 72.66 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.99 - 23.63) | Buy |
| Bollinger Bands (100): | (21.16 - 23.12) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 25.72 while CPRX 8-day simple moving average is 23.30, which is a Buy signal.
-
The stock price of CPRX is 25.72 while Catalyst Pharmaceuticals 20-day SMA is 22.26, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day simple moving average is 22.56 while CPRX share price is 25.72, making it a Buy technically.
-
CPRX stock price is 25.72 and Catalyst Pharmaceuticals 200-day simple moving average is 20.22, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
89
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $25.72. The Score for CPRX is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
3.1B
Price in USD:
25.72
Share Volume:
1.7M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.47
Buy
89
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 25.72 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 25.72 while CPRX 8-day exponential moving average is 15.84, which is a Buy signal.
-
The stock price of CPRX is 25.72 while Catalyst Pharmaceuticals 20-day EMA is 8.19, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 3.66 while CPRX share price is 25.72, making it a Buy technically.
-
CPRX stock price is 25.72 and Catalyst Pharmaceuticals 200-day simple moving average is 0.97, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.32 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 5.56, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 72.66, which suggest Catalyst Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (20.99 - 23.63), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.16 - 23.12), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.